Drug Trial Radar · NCT05181137
A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 19, 2026Latest source record: Sep 5, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
368
Planned (sponsor's estimate)
Start
Nov 5, 2021
Primary completion
Oct 31, 2024
Study completion Mar 31, 2025
Sponsor
- Lead sponsor
- Reistone Biopharma Company LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jan 6, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study that will enroll approximately 368 subjects aged 18 to 75 years old with Moderately to Severely Active Ulcerative Colitis.
Conditions
- Ulcerative Colitis
Interventions
SHR0302Drug
Oral tablets taken once daily (QD)
PlaceboDrug
Oral tablets taken once daily (QD)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical remission at week 8 (Part 1)Time frame: 8 weeks
- Clinical remission at week 52 (Part 2)Time frame: 52 weeks
Locations
113 sites in 5 countries. Site status is shown where the registry gives one.
Digestive Health Specialists
Dothan, Alabama · Completed
Om Research LLC
Lancaster, California · Terminated
Yale University
New Haven, Connecticut · Terminated
IHS Health
Kissimmee, Florida · Active not recruiting
Dade Research Center
Miami, Florida · Terminated
Gastro Florida
Pinellas Park, Florida · Completed
One Health Research Clinic Atlanta, LLC
Norcross, Georgia · Active not recruiting
John Hopkins University
Columbia, Maryland · Terminated
Michigan Medical
Ann Arbor, Michigan · Terminated
Research Institute of Michigan
Chesterfield, Michigan · Withdrawn
NY Scientific
Brooklyn, New York · Terminated
DiGiovanna Institute for Medical Education & Research
North Massapequa, New York · Terminated
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina · Terminated
Charlotte Gastroenterology & Hepatology P.L.L.C
Charlotte, North Carolina · Withdrawn
DDSI
Oklahoma City, Oklahoma · Withdrawn
Central Sooner Research
Oklahoma City, Oklahoma · Terminated
Vanderbilt University Medical Center
Nashville, Tennessee · Terminated
Omni Clinical Research
Houston, Texas · Terminated
UTMB Health
League City, Texas · Terminated
University of Utah
Salt Lake City, Utah · Terminated
McGuire Research Institute
Richmond, Virginia · Terminated
IACT Health
Suffolk, Virginia · Withdrawn
Advocate Aurora Health - Aurora St. Luke's Medical Center
Milwaukee, Wisconsin · Terminated
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China · Recruiting
Anhui Provincial Hospital
Hefei, Anhui, China · Recruiting
Beijing Military Area General Hospital/Seventh Medical Center of PLA General Hospital
Beijing, Beijing Municipality, China · Recruiting
Peking University First Hospital
Beijing, Beijing Municipality, China · Terminated
Peking University Third Hospital
Beijing, Beijing Municipality, China · Recruiting
Tsinghua University Changgung Hospital
Beijing, Beijing Municipality, China · Not yet recruiting
Army Medical Center of PLA
Chongqing, Chongqing Municipality, China · Recruiting
Chongqing People's Hospital
Chongqing, Chongqing Municipality, China · Recruiting
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China · Recruiting
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China · Recruiting
The First Affiliated Hospitial of Xiamen University
Xiamen, Fujian, China · Recruiting
Guangzhou First People's Hospital
Guangzhou, Guangdong, China · Recruiting
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China · Recruiting
The Sixth Affiliated Hospital of Sun Yat-Sen University
Guangzhou, Guangdong, China · Recruiting
Third Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China · Recruiting
Peking University Shenzhen Hospital
Shenzhen, Guangdong, China · Recruiting
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China · Recruiting
Showing 40 of 113 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.